Corus Pharma Inc. raised $60 million in its third round of private financing, among the largest recorded by a biotech company this year. (BioWorld Today)

Corus Pharma Inc. raised $60 million in its third round of private financing, among the largest recorded by a biotech company this year. (BioWorld Today)